7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Kiromic BioPharma, Inc
(NASDAQ:KRBP) 

KRBP stock logo

Kiromic BioPharma, Inc., a target discovery and gene editing company, focuses on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. Its product portfolio include ALEXIS AIDT-1, an allogenic CAR cell product candidate targeting AIDT-1; ALEXIS AIDT-2 EOC, an a...

Founded: 2006
Full Time Employees: 11
CEO: Maurizio Chiriva-Internati  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Kiromic BioPharma Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2,419.39-2,073.76-1,728.14-1,382.51-1,036.88-691.25-345.630
Kiromic BioPharma Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2,442.94-2,093.95-1,744.96-1,395.96-1,046.97-697.98-348.990
Kiromic BioPharma Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 052.17104.35156.52208.69260.87313.04365.21
Kiromic BioPharma (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.6-1.37-1.14-0.91-0.68-0.46-0.230
Kiromic BioPharma P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.4229.5360.4891.43122.38153.33184.28215.23
No extra charts and metrics for this ticker.